targeting cancer | 0.28 | 0.6 | 2211 | 16 | 74 |
targeting cancer cell dormancy | 0.73 | 0.3 | 5027 | 30 | 70 |
targeting cancer with mrna-lipid | 0.14 | 0.5 | 8328 | 32 | 97 |
targeting cancer stem cells | 0.83 | 0.9 | 547 | 27 | 17 |
targeting cancer metabolism | 0.09 | 0.1 | 4212 | 27 | 92 |
targeting cancer with molecular glues | 1.2 | 0.1 | 5384 | 37 | 55 |
targeting cancer with mrna | 1.07 | 0.8 | 4296 | 26 | 20 |
targeting cancer metabolism in the era of | 0.18 | 0.3 | 5935 | 41 | 78 |
targeting cancer cells | 1.23 | 0.9 | 681 | 22 | 68 |
targeting cancer with bispecific antibodies | 1.2 | 1 | 3328 | 43 | 51 |
targeting cancer metastasis | 1.66 | 0.7 | 9688 | 27 | 13 |
targeting cancer glycosylation | 0.07 | 0.5 | 8018 | 30 | 46 |
targeting cancer cell metabolism | 1.42 | 0.7 | 338 | 32 | 62 |
cancer targeting systems inc | 0.25 | 0.9 | 6949 | 28 | 24 |
targeting apoptosis in cancer therapy | 1.9 | 0.1 | 3335 | 37 | 41 |
targeting macrophages in cancer immunotherapy | 1.52 | 0.6 | 9356 | 45 | 85 |
targeting the dna damage response in cancer | 1.03 | 0.7 | 5728 | 43 | 58 |
targeting metabolism for cancer therapy | 0.82 | 0.6 | 481 | 39 | 1 |
auto treatment for cancer molecular targeting | 1.31 | 0.2 | 5639 | 45 | 33 |
monoclonal ddx19b antibody targeting cancer | 1.92 | 1 | 1987 | 43 | 69 |
targeting autophagy in cancer | 0.62 | 0.1 | 1102 | 29 | 78 |